CLOV vs VVX · rev $1.37B vs P/E 32, rev $4.32B
Clover Health Investments Corp (CLOV) versus V2X Inc (VVX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
V2X Inc (VVX) is a aerospace & defense company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VVX revenue for 2024-12-31 was $4.32B. Net income was $34.7M. Revenue was up 9.1% from 2023-12-31 to 2024-12-31. VVX currently screens at market cap $2.77B and trailing P/E 31.6.
CLOV currently screens at market cap $1.55B. VVX currently screens at market cap $2.77B and trailing P/E 31.6.
Not investment advice. Open the CLOV and VVX stock pages for the full models.
Not investment advice.